7 HILLS PHARMA INC
Pioneering first-in-class integrin agonists to treat solid tumors and hematological malignancies
HOUSTON, United States · Founded 2016 · $10.7M raised
- Headquarters
- HOUSTON, Texas
- Employees
- 1–10
- Founded
- 2016
- Business Model
- B2B
- Website
- 7hillspharma.com
- Total Funding
- $10.7M
- Last Round
- $4.7M GrantJun 2018
- Rounds
- 3
About
7 Hills Pharma is a clinical-stage drug development company advancing first-in-class integrin-targeted agonists to improve the effectiveness of immunotherapies for cancer and stem cell transplantation. Its lead molecule Alintegimod is in a Phase 1b/2a trial targeting anti-PD-1-resistant solid tumors, and 7HP935 is in IND-enabling studies to improve CD34+ cell-based therapies for acute leukemias. The company has received over $34 million in NIH and CPRIT grants.
Summary
7 HILLS PHARMA INC is a Biotech company based in HOUSTON, United States, founded in 2016. It has raised $10.7M in total across 3 rounds, most recently a $4.7M Grant round in Jun 2018. Investors include Cancer Prevention and Research Institute of Texas and National Institutes of Health.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2018
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...